Efficacy and safety of rosuvastatin 5 mg in combination with fenofibric acid 135 mg in patients with mixed dyslipidemia - A phase 3 study
Eli M. Roth, Robert S. Rosenson, Dawn M. Carlson, Sandra M. Fukumoto, Carolyn M. Setze, James W. Blasetto, Nardev S. Khurmi, James C. Stolzenbach, Laura A. Williams
Research output: Contribution to journal › Article › peer-review
19Scopus
citations
Fingerprint
Dive into the research topics of 'Efficacy and safety of rosuvastatin 5 mg in combination with fenofibric acid 135 mg in patients with mixed dyslipidemia - A phase 3 study'. Together they form a unique fingerprint.